ArticleMolecular cancer therapeutics2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models.
Yifei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.